Retrophin RTRX 深 滬
等待開盤 08-14 09:30:00 美东时间
24.25
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 24.25
- 總市值 12.38亿
- 52周最高 24.96
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 8.98
- 委 比 0.00%
- 總股本 5105.18万
- 歷史最高 37.04
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.90
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
Allarity Therapeutics appointed Jeff Ervin as its new Chief Financial Officer, succeeding Alexander Epshinsky. Ervin brings over 20 years of leadership experience in healthcare and biotech, including roles at DayDayCook and IMAC Holdings. He holds an MBA from Vanderbilt University and currently serves on the board of Cingulate Inc. Ervin's expertise in public company management and financial strategy is expected to support Allarity's clinical dev...
07-07 12:00
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.
07-04 21:20
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
Pharma bro Martin Shkreli predicted Cassava Sciences stock would fall and the company would miss primary endpoints for its Phase 3 trial.
2024-11-26 00:07
BRIEF-Retrophin Announces Corporate Name Change To Travere Therapeutics Inc
Nov 16 (Reuters) - Retrophin Inc : * RETROPHIN ANNOUNCES CORPORATE NAME CHANGE...
2020-11-16 21:05
BRIEF-Retrophin Reports Q2 Loss Per Share $0.58
July 30 (Reuters) - Retrophin Inc : * RETROPHIN REPORTS SECOND QUA...
2020-07-31 05:19
BRIEF-Retrophin Reports Q2 Loss Per Share $0.58
July 30 (Reuters) - Retrophin Inc : * RETROPHIN REPORTS SECOND QUA...
2020-07-31 05:19
Did Hedge Funds Make The Right Call On Retrophin Inc (RTRX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plow...
2020-07-20 22:37
Retrophin Inc (RTRX): Hedge Funds Sticking Around
In this article you are going to find out whether hedge funds think Retrophin I...
2020-06-17 17:55
Retrophin to Present at the Jefferies 2020 Virtual Healthcare Conference
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) toda...
2020-05-28 04:05
Retrophin: Thesis Falls Back To Sparsentan
Retrophin had two assets disappear from its pipeline this year. Fosmetpantotena...
2019-10-15 11:23
